Published in J Clin Densitom on April 29, 2008
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2012) 4.88
Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 3.11
Interpretation and use of FRAX in clinical practice. Osteoporos Int (2011) 2.43
A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1. Blood (2010) 2.38
The association between higher serum ferritin level and lower bone mineral density is prominent in women ≥45 years of age (KNHANES 2008-2010). Osteoporos Int (2013) 2.07
Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications. Ann Intern Med (2013) 2.06
Causal relationship between the AHSG gene and BMD through fetuin-A and BMI: multiple mediation analysis. Osteoporos Int (2014) 2.02
Official positions of the International Society for Clinical Densitometry (ISCD) on DXA evaluation in children and adolescents. Pediatr Nephrol (2009) 1.98
Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial. J Clin Oncol (2012) 1.66
Osteoporosis imaging: state of the art and advanced imaging. Radiology (2012) 1.58
The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA. Osteoporos Int (2016) 1.37
Effects of ground and joint reaction force exercise on lumbar spine and femoral neck bone mineral density in postmenopausal women: a meta-analysis of randomized controlled trials. BMC Musculoskelet Disord (2012) 1.26
Osteoporosis in young adults: pathophysiology, diagnosis, and management. Osteoporos Int (2012) 1.25
Prevalence and burden of pediatric-onset systemic lupus erythematosus. Nat Rev Rheumatol (2010) 1.23
Lumbar spine bone mineral density in US adults: demographic patterns and relationship with femur neck skeletal status. Osteoporos Int (2011) 1.20
The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005-2008. Osteoporos Int (2011) 1.14
Sex and gender considerations in male patients with osteoporosis. Clin Orthop Relat Res (2011) 1.08
Height loss, vertebral fractures, and the misclassification of osteoporosis. Bone (2010) 1.04
Gender differences in osteoporosis and fractures. Clin Orthop Relat Res (2011) 1.00
Special report on the 2007 adult and pediatric Position Development Conferences of the International Society for Clinical Densitometry. Osteoporos Int (2008) 0.99
Early onset mandibuloacral dysplasia due to compound heterozygous mutations in ZMPSTE24. Am J Med Genet A (2010) 0.98
Recommendations for evaluation and management of bone disease in HIV. Clin Infect Dis (2015) 0.95
Assessing response to osteoporosis therapy. Osteoporos Int (2008) 0.95
A comparison of three different guidelines for osteoporosis treatment in patients with rheumatoid arthritis in Korea. Korean J Intern Med (2010) 0.92
Height, adiposity and body fat distribution and breast density in young women. Breast Cancer Res (2012) 0.92
Osteoporosis care at risk in the United States. Osteoporos Int (2008) 0.91
Skeletal improvement in patients with Gaucher disease type 1: a phase 2 trial of oral eliglustat. Skeletal Radiol (2014) 0.90
Diagnosis and management of osteoporosis in the older senior. Clin Interv Aging (2009) 0.90
Feasibility of FRAX for Prediction of Osteoporotic Vertebral Fractures in Korea. Asian Spine J (2012) 0.87
Age related secretary pattern of growth hormone, insulin-like growth factor-I & insulin-like growth factor binding protein-3 in postmenopausal women. Indian J Med Res (2014) 0.87
[Diagnostic approach to osteoporosis]. Wien Med Wochenschr (2009) 0.87
Osteoporosis in chronic obstructive pulmonary disease. Clin Med Insights Circ Respir Pulm Med (2015) 0.86
A New Predictive Index for Osteoporosis in Men under 70 Years of Age: An Index to Identify Male Candidates for Osteoporosis Screening by Bone Mineral Density. J Osteoporos (2014) 0.85
Osteoporosis in men. Nat Rev Endocrinol (2013) 0.85
Bisphophonates in CKD patients with low bone mineral density. ScientificWorldJournal (2013) 0.84
Comprehensive Assessment of Osteoporosis and Bone Fragility with CT Colonography. Radiology (2015) 0.84
Dose-response effect of 40 weeks of resistance training on bone mineral density in older adults. Osteoporos Int (2010) 0.84
Bone and the perimenopause. Obstet Gynecol Clin North Am (2011) 0.84
Vitamin D deficiency in children with epilepsy: Do we need to detect and treat it? J Pediatr Neurosci (2013) 0.83
Occurrence of osteoporosis & factors determining bone mineral loss in young adults with Graves' disease. Indian J Med Res (2015) 0.83
Incidence and risk factors for osteoporotic vertebral fracture in low-income community-dwelling elderly: a population-based prospective cohort study in Brazil. The São Paulo Ageing & Health (SPAH) Study. Osteoporos Int (2014) 0.82
Clinical Guidelines for Management of Bone Health in Rett Syndrome Based on Expert Consensus and Available Evidence. PLoS One (2016) 0.82
Bisphosphonates for the treatment of osteoporosis: insights for clinicians. Ther Adv Chronic Dis (2010) 0.82
Acute bone marker responses to whole-body vibration and resistance exercise in young women. J Clin Densitom (2012) 0.82
Epidemiology of hip fracture in Tucuman, Argentina. Osteoporos Int (2009) 0.80
Lean tissue mass and energy expenditure are retained in hypogonadal men with spinal cord injury after discontinuation of testosterone replacement therapy. J Spinal Cord Med (2014) 0.80
A randomized phase II trial evaluating different schedules of zoledronic acid on bone mineral density in patients with prostate cancer beginning androgen deprivation therapy. Clin Genitourin Cancer (2013) 0.80
High prevalence of low bone mass and associated factors in Korean HIV-positive male patients undergoing antiretroviral therapy. J Int AIDS Soc (2014) 0.80
Chronic kidney disease and the skeleton. Bone Res (2014) 0.79
Age and sex differences in estimated tibia strength: influence of measurement site. J Clin Densitom (2012) 0.79
Influence of weight training on skeletal health of breast cancer survivors with or at risk for breast cancer-related lymphedema. J Cancer Surviv (2014) 0.79
Physical activity benefits bone density and bone-related hormones in adult men with cervical spinal cord injury. Eur J Appl Physiol (2012) 0.79
Follow-up of bone mineral density and body composition in adolescents with restrictive anorexia nervosa: role of dual-energy X-ray absorptiometry. Eur J Clin Nutr (2013) 0.79
Metabolic bone disease in the bariatric surgery patient. J Obes (2010) 0.79
Osteoporosis in men: insights for the clinician. Ther Adv Musculoskelet Dis (2011) 0.79
Age and sex differences in tibia morphology in healthy adult Caucasians. Bone (2012) 0.78
Appraising osteoporosis care gaps. Rheumatol Int (2011) 0.78
Is there any association between leptin levels and bone mineral density in haemophiliac men? Arch Med Sci (2013) 0.78
State of the art systematic review of bone disease in anorexia nervosa. Int J Eat Disord (2015) 0.78
Common mistakes in the clinical use of bone mineral density testing. Nat Clin Pract Rheumatol (2008) 0.78
Understanding Referral Patterns for Bone Mineral Density Testing among Family Physicians: A Qualitative Descriptive Study. J Osteoporos (2016) 0.78
A hip analysis protocol for pediatric bone densitometry: the Iowa Bone Development Study. J Clin Densitom (2010) 0.78
Femur ultrasound (FemUS)--first clinical results on hip fracture discrimination and estimation of femoral BMD. Osteoporos Int (2009) 0.78
Relationship of thoracic kyphosis and lumbar lordosis to bone mineral density in women. Osteoporos Int (2013) 0.78
[Diagnosis of osteoporosis in geriatric patients - possibilities and limitations]. Wien Med Wochenschr (2011) 0.78
Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis. J Endocrinol Invest (2016) 0.77
A DXA Whole Body Composition Cross-Calibration Experience: Evaluation With Humans, Spine, and Whole Body Phantoms. J Clin Densitom (2015) 0.77
QCT bone mineral density responses to 1 year of oral bisphosphonate after total knee replacement for knee osteoarthritis. Osteoporos Int (2012) 0.77
Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis. Ther Clin Risk Manag (2009) 0.77
The effect of growth hormone deficiency on size-corrected bone mineral measures in pre-pubertal children. Osteoporos Int (2011) 0.76
Osteoporosis screening preferences of older adults. J Clin Densitom (2009) 0.76
The risk of osteoporotic fractures according to the FRAX model in Korean patients with rheumatoid arthritis. J Korean Med Sci (2014) 0.76
Relationship of vitamin D status and bone mass according to vitamin D-binding protein genotypes. Nutr J (2015) 0.76
The assessment of bone mineral content and density of the lumbar spine and proximal femur in US submariners. Osteoporos Int (2014) 0.76
Bone status in adults with early-onset juvenile idiopathic arthritis following 1-year anti-TNFα therapy and discontinuation of glucocorticoids. Rheumatol Int (2013) 0.76
Blood levels related to the Z-score of bone mineral density in young males and females. J Phys Ther Sci (2015) 0.76
Impact of femoral neck and lumbar spine BMD discordances on FRAX probabilities in women: a meta-analysis of international cohorts. Calcif Tissue Int (2014) 0.76
Bone: Using FRAX wisely: lessons from Switzerland and beyond. Nat Rev Endocrinol (2010) 0.75
Arteriovenous fistula affects bone mineral density measurements in end-stage renal failure patients. Clin J Am Soc Nephrol (2009) 0.75
Bone mineral density, thyroid function, and gonadal status in young adult survivors of childhood cancer. Contemp Oncol (Pozn) (2014) 0.75
Advanced Analysis Techniques Improve Infant Bone and Body Composition Measures by Dual-Energy X-Ray Absorptiometry. J Pediatr (2016) 0.75
The effects of the Korean reference value on the prevalence of osteoporosis and the prediction of fracture risk. BMC Musculoskelet Disord (2015) 0.75
Bone mineral density and mammographic density in Mexican women. Cancer Causes Control (2016) 0.75
Influence of Body Composition, Oral Contraceptive Use, and Physical Activity on Bone Mineral Density in Premenopausal Women. Int J Exerc Sci (2009) 0.75
SIDE TO SIDE DIFFERENCES BETWEEN DOMINANT AND NON-DOMINANT ARM'S BONE DENSITY AND ISOMETRIC HANDGRIP STRENGTH IN MALES AND FEMALES AGED 40-65 YEARS OLD. Mater Sociomed (2016) 0.75
Bone Density Screening and Re-screening in Postmenopausal Women and Older Men. Curr Osteoporos Rep (2015) 0.75
Positioner and clothing artifact can affect one-third radius bone mineral density measurement. J Clin Densitom (2012) 0.75
Prevalence of Fracture in Healthy Iranian Children Aged 9-18 Years and Associated Risk Factors; A Population Based Study. Bull Emerg Trauma (2017) 0.75
Osteoporosis screening: mixed messages in primary care. Am Fam Physician (2009) 0.75
Comparison of the Spine and Hip BMD Assessments Derived from Quantitative Computed Tomography. Int J Endocrinol (2015) 0.75
Effect of including historical height and radius BMD measurement on sarco-osteoporosis prevalence. J Cachexia Sarcopenia Muscle (2012) 0.75
Association between bone mineral density, muscle strength, and vitamin D status in patients with myasthenia gravis: a cross-sectional study. Osteoporos Int (2017) 0.75
Osteosarcopenia: where bone, muscle, and fat collide. Osteoporos Int (2017) 0.75
Effect of IV contrast on lumbar trabecular attenuation at routine abdominal CT: correlation with DXA and implications for opportunistic osteoporosis screening. Osteoporos Int (2015) 0.75
Applying ethnic-specific bone mineral density T-scores to Chinese women in the USA. Osteoporos Int (2016) 0.75
Denosumab in postmenopausal women with low bone mineral density. N Engl J Med (2006) 10.02
The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med (2003) 7.25
Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab (2005) 5.64
Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc (2006) 5.32
One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis. N Engl J Med (2005) 4.03
Official positions of the International Society for Clinical Densitometry. J Clin Densitom (2004) 3.63
Mechanisms of anabolic therapies for osteoporosis. N Engl J Med (2007) 3.33
HPLC method for 25-hydroxyvitamin D measurement: comparison with contemporary assays. Clin Chem (2006) 3.16
Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 3.11
Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev (2005) 3.01
Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res (2015) 2.74
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract (2004) 2.69
International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone (2008) 2.53
Precision assessment and radiation safety for dual-energy X-ray absorptiometry: position paper of the International Society for Clinical Densitometry. J Clin Densitom (2005) 2.44
Effects of denosumab on bone mineral density and bone turnover in postmenopausal women. J Clin Endocrinol Metab (2008) 2.43
Clinical review: Rare causes of hypercalcemia. J Clin Endocrinol Metab (2005) 2.38
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract (2011) 2.29
Executive summary of the 2013 International Society for Clinical Densitometry Position Development Conference on bone densitometry. J Clin Densitom (2013) 2.29
Clinical value of monitoring BMD in patients treated with bisphosphonates for osteoporosis. J Bone Miner Res (2009) 2.24
Clinical use of quantitative computed tomography and peripheral quantitative computed tomography in the management of osteoporosis in adults: the 2007 ISCD Official Positions. J Clin Densitom (2008) 2.21
Unreported vertebral body compression fractures at abdominal multidetector CT. Radiology (2013) 2.17
Progressive bone deficit in epilepsy. Neurology (2007) 2.14
The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab (2008) 2.12
Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications. Ann Intern Med (2013) 2.06
Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure. J Bone Miner Res (2008) 2.04
High-resolution peripheral quantitative computed tomography can assess microstructural and mechanical properties of human distal tibial bone. J Bone Miner Res (2010) 2.01
Official positions of the International Society for Clinical Densitometry (ISCD) on DXA evaluation in children and adolescents. Pediatr Nephrol (2009) 1.98
Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2012) 1.96
Obesity is not protective against fracture in postmenopausal women: GLOW. Am J Med (2011) 1.95
The 2002 Canadian bone densitometry recommendations: take-home messages. CMAJ (2002) 1.92
Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures. J Bone Miner Res (2012) 1.92
Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol Metab (2006) 1.91
Differences in bone microarchitecture between postmenopausal Chinese-American and white women. J Bone Miner Res (2011) 1.86
Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res (2014) 1.86
Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention. J Bone Miner Res (2012) 1.84
Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans. J Bone Miner Res (2008) 1.82
Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study. J Bone Miner Res (2005) 1.81
Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday. Am J Med (2012) 1.80
Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone (2012) 1.79
Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX. J Bone Miner Res (2012) 1.77
Application of high-resolution skeletal imaging to measurements of volumetric BMD and skeletal microarchitecture in Chinese-American and white women: explanation of a paradox. J Bone Miner Res (2009) 1.76
National Osteoporosis Foundation 2008 Clinician's Guide to Prevention and Treatment of Osteoporosis and the World Health Organization Fracture Risk Assessment Tool (FRAX): what they mean to the bone densitometrist and bone technologist. J Clin Densitom (2008) 1.76
Effects of denosumab on bone histomorphometry: the FREEDOM and STAND studies. J Bone Miner Res (2010) 1.74
25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. Am J Clin Nutr (2008) 1.73
Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. J Clin Endocrinol Metab (2004) 1.71
Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis. J Bone Miner Res (2005) 1.68
Diagnosis and management of vertebral fractures in elderly adults. Am J Med (2002) 1.68
Quantitative ultrasound in the management of osteoporosis: the 2007 ISCD Official Positions. J Clin Densitom (2008) 1.66
Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature. J Bone Miner Res (2012) 1.63
Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women. Mayo Clin Proc (2010) 1.62
Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW). J Bone Miner Res (2014) 1.62
Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass. J Clin Endocrinol Metab (2011) 1.59
Goal-directed treatment of osteoporosis. J Bone Miner Res (2013) 1.58
Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate. J Clin Endocrinol Metab (2008) 1.53
Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab (2007) 1.51
Combination therapy with risedronate and teriparatide in male osteoporosis. Endocrine (2012) 1.50
Role of exercise and nutrition status on bone mineral density in cystic fibrosis. J Cyst Fibros (2003) 1.48
Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis: bone density, mass, and strength of the radius, and wrist fracture. Menopause (2013) 1.47
Dynamic and structural properties of the skeleton in hypoparathyroidism. J Bone Miner Res (2008) 1.46
Algorithm for the management of osteoporosis. South Med J (2010) 1.45
A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS One (2012) 1.44
Vertebral Fracture Assessment: the 2007 ISCD Official Positions. J Clin Densitom (2008) 1.42
Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW). J Clin Endocrinol Metab (2014) 1.41
Accelerated fracture healing with teriparatide. Arq Bras Endocrinol Metabol (2013) 1.41
The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. J Clin Endocrinol Metab (2003) 1.41
Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference. J Clin Densitom (2008) 1.41
"Incipient" primary hyperparathyroidism: a "forme fruste" of an old disease. J Clin Endocrinol Metab (2003) 1.39
Simultaneous screening for osteoporosis at CT colonography: bone mineral density assessment using MDCT attenuation techniques compared with the DXA reference standard. J Bone Miner Res (2011) 1.38
Skeletal histomorphometry in subjects on teriparatide or zoledronic acid therapy (SHOTZ) study: a randomized controlled trial. J Clin Endocrinol Metab (2012) 1.38
Osteonecrosis of the jaw: more research needed. J Bone Miner Res (2006) 1.36
Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab (2014) 1.35
A case of an unusual subtrochanteric fracture in a patient receiving denosumab. Endocr Pract (2013) 1.35
Better skeletal microstructure confers greater mechanical advantages in Chinese-American women versus white women. J Bone Miner Res (2011) 1.34
Perspectives on glucocorticoid-induced osteoporosis. Bone (2004) 1.34
Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study. J Bone Miner Res (2008) 1.32
PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism. J Bone Miner Res (2011) 1.30
Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures. J Clin Endocrinol Metab (2003) 1.30
Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women. J Bone Miner Res (2012) 1.29
Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: a multicenter, randomized, open-label, crossover study. Clin Ther (2002) 1.27
Therapy of hypoparathyroidism with PTH(1-84): a prospective four-year investigation of efficacy and safety. J Clin Endocrinol Metab (2012) 1.26
Benefits and risks of bisphosphonate therapy for osteoporosis. J Clin Endocrinol Metab (2012) 1.24